In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other best ...

Equities research analysts at Zacks Research lowered their Q1 2025 earnings per share estimates for shares of United ...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the ...

Proficio Capital Partners LLC bought a new stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the fourth ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molecular Partners (MOLN – Research Report), ...

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm ...

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other best healthcare stocks for long-term investment. In the US, healthcare ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season. Over the next few years, therapeutic companies, which ...

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other Renaissance Technologies portfolio’s top stock picks. The American quant ...